UBS Group’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $218K | Buy |
153,172
+79,180
| +107% | +$112K | ﹤0.01% | 5426 |
|
|
2025
Q1 | $113K | Buy |
73,992
+4,529
| +7% | +$6.93K | ﹤0.01% | 5698 |
|
|
2024
Q4 | $172K | Buy |
69,463
+37,611
| +118% | +$93.3K | ﹤0.01% | 5341 |
|
|
2024
Q3 | $36.6K | Sell |
31,852
-1,939
| -6% | -$2.23K | ﹤0.01% | 5820 |
|
|
2024
Q2 | $37.2K | Sell |
33,791
-36,610
| -52% | -$40.3K | ﹤0.01% | 5764 |
|
|
2024
Q1 | $87.3K | Buy |
70,401
+50,777
| +259% | +$63K | ﹤0.01% | 5129 |
|
|
2023
Q4 | $20.6K | Sell |
19,624
-32,054
| -62% | -$33.7K | ﹤0.01% | 5883 |
|
|
2023
Q3 | $354K | Buy |
51,678
+48,864
| +1,736% | +$335K | ﹤0.01% | 3851 |
|
|
2023
Q2 | $29.2K | Buy |
2,814
+781
| +38% | +$8.1K | ﹤0.01% | 5658 |
|
|
2023
Q1 | $16.4K | Sell |
2,033
-373
| -16% | -$3.02K | ﹤0.01% | 6141 |
|
|
2022
Q4 | $37.9K | Sell |
2,406
-465
| -16% | -$7.32K | ﹤0.01% | 5857 |
|
|
2022
Q3 | $45K | Buy |
2,871
+465
| +19% | +$7.29K | ﹤0.01% | 5370 |
|
|
2022
Q2 | $34K | Buy |
2,406
+704
| +41% | +$9.95K | ﹤0.01% | 5218 |
|
|
2022
Q1 | $29K | Sell |
1,702
-44,486
| -96% | -$758K | ﹤0.01% | 5989 |
|
|
2021
Q4 | $671K | Buy |
46,188
+44,538
| +2,699% | +$647K | ﹤0.01% | 3757 |
|
|
2021
Q3 | $30K | Sell |
1,650
-1,249
| -43% | -$22.7K | ﹤0.01% | 5618 |
|
|
2021
Q2 | $51K | Sell |
2,899
-3,467
| -54% | -$61K | ﹤0.01% | 5343 |
|
|
2021
Q1 | $160K | Buy |
6,366
+5,060
| +387% | +$127K | ﹤0.01% | 4645 |
|
|
2020
Q4 | $8K | Sell |
1,306
-3,710
| -74% | -$22.7K | ﹤0.01% | 6578 |
|
|
2020
Q3 | $13K | Buy |
5,016
+4,469
| +817% | +$11.6K | ﹤0.01% | 5746 |
|
|
2020
Q2 | $1K | Sell |
547
-18,450
| -97% | -$33.7K | ﹤0.01% | 6867 |
|
|
2020
Q1 | $20K | Sell |
18,997
-18,809
| -50% | -$19.8K | ﹤0.01% | 5575 |
|
|
2019
Q4 | $71K | Buy |
37,806
+28,749
| +317% | +$54K | ﹤0.01% | 5129 |
|
|
2019
Q3 | $10K | Sell |
9,057
-907,495
| -99% | -$1M | ﹤0.01% | 6180 |
|
|
2019
Q2 | $2.01M | Buy |
916,552
+233,013
| +34% | +$510K | ﹤0.01% | 2514 |
|
|
2019
Q1 | $4.09M | Sell |
683,539
-633,721
| -48% | -$3.8M | ﹤0.01% | 1911 |
|
|
2018
Q4 | $9.73M | Buy |
1,317,260
+1,317,241
| +6,932,847% | +$9.73M | ﹤0.01% | 1244 |
|
|
2018
Q3 | $0 | Hold |
19
| – | – | ﹤0.01% | 7011 |
|
|
2018
Q2 | $0 | Sell |
19
-2,414
| -99% | – | ﹤0.01% | 6998 |
|
|
2018
Q1 | $43K | Sell |
2,433
-260
| -10% | -$4.6K | ﹤0.01% | 4972 |
|
|
2017
Q4 | $66K | Sell |
2,693
-3,362
| -56% | -$82.4K | ﹤0.01% | 4691 |
|
|
2017
Q3 | $156K | Buy |
6,055
+2,768
| +84% | +$71.3K | ﹤0.01% | 4170 |
|
|
2017
Q2 | $90K | Sell |
3,287
-1,175
| -26% | -$32.2K | ﹤0.01% | 4348 |
|
|
2017
Q1 | $133K | Buy |
4,462
+1,681
| +60% | +$50.1K | ﹤0.01% | 4059 |
|
|
2016
Q4 | $75K | Buy |
2,781
+578
| +26% | +$15.6K | ﹤0.01% | 4601 |
|
|
2016
Q3 | $56K | Buy |
2,203
+1,262
| +134% | +$32.1K | ﹤0.01% | 4553 |
|
|
2016
Q2 | $17K | Buy |
941
+308
| +49% | +$5.56K | ﹤0.01% | 5528 |
|
|
2016
Q1 | $12K | Buy |
633
+524
| +481% | +$9.93K | ﹤0.01% | 5686 |
|
|
2015
Q4 | $3K | Buy |
+109
| New | +$3K | ﹤0.01% | 6459 |
|